These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9618287)
1. An in vitro model to study mesenchymal-epithelial transformation. Ouyang P Biochem Biophys Res Commun; 1998 May; 246(3):771-6. PubMed ID: 9618287 [TBL] [Abstract][Full Text] [Related]
2. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions. Lamorte L; Royal I; Naujokas M; Park M Mol Biol Cell; 2002 May; 13(5):1449-61. PubMed ID: 12006644 [TBL] [Abstract][Full Text] [Related]
3. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor function and c-Met expression in human lens epithelial cells. Wormstone IM; Tamiya S; Marcantonio JM; Reddan JR Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4216-22. PubMed ID: 11095618 [TBL] [Abstract][Full Text] [Related]
5. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice. Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611 [TBL] [Abstract][Full Text] [Related]
6. Establishment of a functional HGF/C-MET autocrine loop in spontaneous transformants of WB-F344 rat liver stem-like cells. Presnell SC; Hooth MJ; Borchert KM; Coleman WB; Grisham JW; Smith GJ Hepatology; 1998 Nov; 28(5):1253-9. PubMed ID: 9794909 [TBL] [Abstract][Full Text] [Related]
7. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c. MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502 [TBL] [Abstract][Full Text] [Related]
8. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. Michieli P; Basilico C; Pennacchietti S; Maffè A; Tamagnone L; Giordano S; Bardelli A; Comoglio PM Oncogene; 1999 Sep; 18(37):5221-31. PubMed ID: 10498872 [TBL] [Abstract][Full Text] [Related]
9. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor. Zhang KX; Ward KR; Schrader JW Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946 [TBL] [Abstract][Full Text] [Related]
10. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells. Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor expression in the developing myocardium: evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression. Song W; Majka SM; McGuire PG Dev Dyn; 1999 Jan; 214(1):92-100. PubMed ID: 9915579 [TBL] [Abstract][Full Text] [Related]
12. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network. Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586 [TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor and Madin-Darby canine kidney cells: in vitro models of epithelial cell movement and morphogenesis. Balkovetz DF Microsc Res Tech; 1998 Dec; 43(5):456-63. PubMed ID: 9858342 [TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression. Liu Y; Centracchio JN; Lin L; Sun AM; Dworkin LD Exp Cell Res; 1998 Jul; 242(1):174-85. PubMed ID: 9665815 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414 [TBL] [Abstract][Full Text] [Related]
17. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Briggs MC; Grierson I; Hiscott P; Hunt JA Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510 [TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor is essential for migration of myogenic cells and promotes their proliferation during the early periods of tongue morphogenesis in mouse embryos. Amano O; Yamane A; Shimada M; Koshimizu U; Nakamura T; Iseki S Dev Dyn; 2002 Mar; 223(2):169-79. PubMed ID: 11836782 [TBL] [Abstract][Full Text] [Related]
20. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis. Taylor GA; Jeffers M; Webb CP; Koo HM; Anver M; Sekiguchi K; Vande Woude GF Oncogene; 1998 Sep; 17(9):1179-83. PubMed ID: 9764829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]